Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ferrosan Medical Devices Group A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   1.0% 1.5% 1.0% 0.5% 0.5% 0.5% 4.0% 4.0%   Credit score (0-100)   88 78 87 99 99 99 49 49   Credit rating   A A A AAA AAA AAA BBB BBB   Credit limit (mDKK)   54.1 2.2 23.1 62.5 75.0 83.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   486 530 528 622 720 810 810 810   Gross profit   283 340 335 487 563 605 0.0 0.0   EBITDA   107 103 121 225 286 322 0.0 0.0   EBIT   1.4 -8.3 18.7 127 187 213 0.0 0.0   Pre-tax profit (PTP)   9.6 -6.1 22.9 67.8 135.5 164.3 0.0 0.0   Net earnings   9.6 -6.1 22.9 50.8 102.9 136.9 0.0 0.0   Pre-tax profit without non-rec. items   9.6 -6.1 22.9 67.8 135 164 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   71.1 90.1 101 117 306 325 0.0 0.0   Shareholders equity total   832 592 335 469 562 620 615 615   Interest-bearing liabilities   0.0 0.0 0.0 94.2 935 899 0.0 0.0   Balance sheet total (assets)   1,908 1,850 1,757 1,943 1,974 2,016 615 615   Net Debt   -35.8 -49.7 -16.2 77.0 935 883 -516 -516     See the entire balance sheet 1.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   486 530 528 622 720 810 810 810   Net sales growth   131.9% 9.0% -0.4% 17.9% 15.7% 12.5% 0.0% 0.0%   Gross profit   283 340 335 487 563 605 0.0 0.0   Gross profit growth   150.3% 19.9% -1.3% 45.1% 15.6% 7.6% -100.0% 0.0%   Employees   253 269 287 0 345 360 0 0   Employee growth %   11.5% 6.3% 6.7% -100.0% 0.0% 4.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,908 1,850 1,757 1,943 1,974 2,016 615 615   Balance sheet change%   -5.8% -3.0% -5.0% 10.6% 1.6% 2.2% -69.5% 0.0%   Added value   106.9 102.9 121.2 225.2 284.9 321.6 0.0 0.0   Added value %   22.0% 19.4% 23.0% 36.2% 39.6% 39.7% 0.0% 0.0%   Investments   -85 -96 -92 -66 114 -48 -325 0   Net sales trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   22.0% 19.4% 23.0% 36.2% 39.8% 39.7% 0.0% 0.0%   EBIT %   0.3% -1.6% 3.5% 20.4% 25.9% 26.3% 0.0% 0.0%   EBIT to gross profit (%)   0.5% -2.4% 5.6% 26.1% 33.2% 35.3% 0.0% 0.0%   Net Earnings %   2.0% -1.2% 4.3% 8.2% 14.3% 16.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   23.6% 19.8% 23.8% 24.0% 28.2% 30.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.0% -1.2% 4.3% 10.9% 18.8% 20.3% 0.0% 0.0%   ROA %   0.5% -0.3% 1.3% 7.0% 9.6% 11.1% 0.0% 0.0%   ROI %   0.5% -0.3% 1.3% 7.7% 11.7% 13.6% 0.0% 0.0%   ROE %   1.2% -0.9% 4.9% 12.6% 20.0% 23.2% 0.0% 0.0%   1.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   75.4% 69.9% 58.0% 24.1% 28.5% 30.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 237.0% 196.0% 172.3% 0.0% 0.0%   Relative net indebtedness %   -7.4% -9.4% -3.1% 234.2% 196.0% 170.2% -63.7% -63.7%   Net int. bear. debt to EBITDA, %   -33.5% -48.2% -13.4% 34.2% 326.4% 274.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 20.1% 166.5% 145.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 129.3% 10.3% 6.3% 0.0% 0.0%   1.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.9 0.6 1.3 0.0 0.0   Cash and cash equivalent   35.8 49.7 16.2 17.2 0.0 16.3 0.0 0.0   1.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 53.8 54.4 57.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 265.8 157.2 310.5 0.0 0.0   Current assets / Net sales %   37.0% 37.1% 34.3% 31.5% 28.8% 31.3% 63.7% 63.7%   Net working capital   179.9 196.8 180.9 -33.6 -123.2 54.5 0.0 0.0   Net working capital %   37.0% 37.1% 34.3% -5.4% -17.1% 6.7% 0.0% 0.0%   1.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   2 2 2 0 2 2 0 0   Added value / employee   0 0 0 0 1 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 1 1 0 0   EBIT / employee   0 -0 0 0 1 1 0 0   Net earnings / employee   0 -0 0 0 0 0 0 0